Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.

SNGX

Soligenix (SNGX)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SNGX
DataOraFonteTitoloSimboloCompagnia
16/12/202413:30PR Newswire (US)Soligenix Initiates Confirmatory Phase 3 Clinical Trial of HyBryte™ for the Treatment of Cutaneous T-Cell LymphomaNASDAQ:SNGXSoligenix Inc
13/12/202423:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SNGXSoligenix Inc
02/12/202413:30PR Newswire (US)HyBryte™ Clinical Results Demonstrate Continued Improvement Post-TreatmentNASDAQ:SNGXSoligenix Inc
19/11/202413:30PR Newswire (US)Soligenix Announces Formation of European Medical Advisory Board for Cutaneous T-Cell LymphomaNASDAQ:SNGXSoligenix Inc
14/11/202413:15PR Newswire (US)Soligenix Initiates a Phase 2 Clinical Trial of SGX945 (dusquetide) for the treatment of Behçet's DiseaseNASDAQ:SNGXSoligenix Inc
08/11/202422:14Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SNGXSoligenix Inc
08/11/202422:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SNGXSoligenix Inc
08/11/202413:30PR Newswire (US)Soligenix Announces Recent Accomplishments And Third Quarter 2024 Financial ResultsNASDAQ:SNGXSoligenix Inc
24/10/202413:30GlobeNewswire Inc.Soligenix, Inc. to Present at the 2024 ThinkEquity ConferenceNASDAQ:SNGXSoligenix Inc
22/10/202413:30PR Newswire (US)Soligenix Receives Hong Kong Patent for Improved Production of Synthetic HypericinNASDAQ:SNGXSoligenix Inc
16/10/202413:30PR Newswire (US)Soligenix Invited to Present at Upcoming Investor ConferencesNASDAQ:SNGXSoligenix Inc
11/10/202422:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SNGXSoligenix Inc
07/10/202413:30PR Newswire (US)HyBryte™ Expanded Treatment Results to be Presented at the European Organisation for Research and Treatment of Cancer ConferenceNASDAQ:SNGXSoligenix Inc
03/10/202413:30PR Newswire (US)Soligenix Announces Partnership with Sterling Pharma SolutionsNASDAQ:SNGXSoligenix Inc
16/09/202413:30PR Newswire (US)Join Soligenix's Exclusive Live Investor Webinar and Q&A Session on September 18, 2024NASDAQ:SNGXSoligenix Inc
03/09/202413:30PR Newswire (US)Soligenix Receives European Patent for Improved Production of Synthetic HypericinNASDAQ:SNGXSoligenix Inc
16/08/202422:19Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:SNGXSoligenix Inc
09/08/202413:30PR Newswire (US)Soligenix Announces Recent Accomplishments And Second Quarter 2024 Financial ResultsNASDAQ:SNGXSoligenix Inc
05/08/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SNGXSoligenix Inc
01/08/202415:00GlobeNewswire Inc.Strong Clinical Momentum for Soligenix's HyBryte™ in Treating Cutaneous T-Cell Lymphoma; PCG Digital Exclusive with Dr. Brian PoligoneNASDAQ:SNGXSoligenix Inc
15/07/202416:16GlobeNewswire Inc.PRISM MarketView Features Q&A with Dr. Ellen Kim: Soligenix's HyBryte™— Lighting the Way Towards Commercial Success with Promising FLASH Study ResultsNASDAQ:SNGXSoligenix Inc
09/07/202413:30PR Newswire (US)Expanded HyBryte™ Treatment Demonstrating Positive Outcomes in Early-Stage Cutaneous T-Cell LymphomaNASDAQ:SNGXSoligenix Inc
25/06/202413:30PR Newswire (US)Soligenix Announces Positive Clinical Results from a Comparative Study Evaluating HyBryte™ Against Valchlor® in the Treatment of Cutaneous T-Cell LymphomaNASDAQ:SNGXSoligenix Inc
14/06/202413:30PR Newswire (US)A Comparison of Vaccine Technologies to be Presented at the ASM Microbe ConferenceNASDAQ:SNGXSoligenix Inc
05/06/202414:00GlobeNewswire Inc.Setting the Stage for Success: PRISM MarketView Highlights Soligenix's Promising HyBryte™ Replication TrialNASDAQ:SNGXSoligenix Inc
31/05/202413:30PR Newswire (US)Soligenix Announces Reverse Stock SplitNASDAQ:SNGXSoligenix Inc
29/05/202422:05Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SNGXSoligenix Inc
29/05/202413:30PR Newswire (US)Soligenix Encourages Stockholders to Vote their Shares at the Annual MeetingNASDAQ:SNGXSoligenix Inc
24/05/202413:30PR Newswire (US)Soligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual MeetingNASDAQ:SNGXSoligenix Inc
23/05/202413:30PR Newswire (US)Soligenix Encourages Stockholders to Vote "FOR" Reverse Stock SplitNASDAQ:SNGXSoligenix Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SNGX
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network